Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Altman Z-score

Rigel Pharmaceuticals Altman Z-score Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Altman Z-score from 2010 to 2020.
  • Rigel Pharmaceuticals Altman Z-score for the quarter ending June 06, 2020 was -10.99 a 21.16% decrease of -2.33 year over year
  • Rigel Pharmaceuticals Altman Z-score for the last 12 months ending June 06, 2020 was -9.35 a 10.46% decrease of -0.98 year over year
  • Rigel Pharmaceuticals Annual Altman Z-score for 2019 was -10.44 a 83.26% decrease of -8.69 from 2018
  • Rigel Pharmaceuticals Annual Altman Z-score for 2018 was -1.75 a -46.03% increase of 0.80 from 2017
  • Rigel Pharmaceuticals Annual Altman Z-score for 2017 was -2.55 a -454.95% increase of 11.61 from 2016
Other Balance Sheet Metrics:
  • Rigel Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $123m a 3.29% increase of 4m year over year
  • Rigel Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a 91.46% increase of 1m year over year
  • Rigel Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $103m a 2.73% increase of 3m year over year
View Chart On Koyfin

Quarterly RIGL Altman Z-score Data

06/2020-10.99
03/2020-4.75
12/2019-10.54
09/2019-8.67
06/2019-9.08
03/2019-7.31
12/2018-0.25
09/2018-0.13
06/20186.21
12/20172.55

Annual RIGL Altman Z-score Data

2019-10.44
2018-1.75
2017-2.55
2016-14.16
2015-6.62
2014-3.40
20137.67
201215.59
201110.41
201010.24